Haichang Medical Plastics Embarks on First Voyage to Australia: Taking Crucial First Step in Internationalization

On May 22nd, as the convoy of containers carrying the first batch of medical packaging products for export to Australia set off with a whistle, Haichang Medplas officially embarked on a new chapter of its internationalization strategy, achieving a "zero breakthrough" for Shanghai Pharmaceutical's pharmaceutical packaging materials in the mainstream international market. The smooth delivery of this first order to Australia marks the entry of Haichang Medplas' internationalization strategy into a substantive advancement phase. In the face of intense competition, Haichang Medplas has strategically positioned itself internationally with forward-looking vision and efficient execution. By successfully obtaining the U.S. FDA-DMF filing number in 2023, the company significantly enhances its international competitiveness, laying a solid foundation for Haichang Medplas to further expand into international markets.